Eastern Europe

Two Russian drugs against COVID-19 registered abroad

17:01, 25 December 2020
Two Russian drugs against COVID-19 registered abroad Photo: Moskva News Agency

The Russian pharmaceutical company R-Pharm has approved the drugs Coronavir and Artlegia against coronavirus in Azerbaijan. This is the first time that domestic drugs for COVID-19 have been registered outside the Russian Federation.


According to the company, the Russian Health Ministry guideline for the treatment of coronavirus includes both drugs. The process of their registration in Azerbaijan was over on December 25.

The drugs of the R-Pharm group of companies, used for the treatment of coronavirus infection, have been registered outside the Russian Federation for the first time, the statement says.

In Russia, the drug Coronavir was registered by the country's Ministry of Health in July 2020. It is used in the therapy of mild to moderate COVID-19 and treats the virus itself, not its effects. Artlegia fights a moderate form of COVID-19 to suppress hyperinflammation. It also prevents severe damage to the lungs and other organs caused by COVID-19, RIA Novosti reports.

NEWS.ru reported earlier that Russian vaccines are effective against COVID-19 mutations.